CIDRAP newsletters options
More than 28 million extra years of life were lost among 31 well-off nations.
The initial COVID-19 vaccine campaign in the United States was associated with fewer infections, emergency department (ED) visits, and hospitalizations among adults 65 and older, finds a study yesterday in The Lancet.
A new report from the Centers for Disease Control and Prevention (CDC) shows that progress against healthcare-associated infections (HAIs), including those caused by antibiotic-resistant bacteria, took a step back in 2020.
"Please know we have conducted a thorough review of the safety data."
The high protection was found even amid high Alpha and Delta variant circulation.
Covaxin, made by Bharat Biotech, is an inactivated vaccine given in two doses 4 weeks apart.
COVID-19 didn't appear to spread efficiently within and among teams last fall.
Spanish, Italian, and UK physicians reported high levels of depression and anxiety during the first two waves of the COVID-19 pandemic, finds a study yesterday in PLOS One.
A hybrid of natural and vaccine immunity may protect better against breakthrough infections.
The ACIP recommendation now goes to CDC head Walensky for final approval.
Also, new CDC data show why immune-compromised people need an added COVID vaccine dose.
Among children with community-acquired pneumonia (CAP) who were discharged from the hospital within 48 hours but required further outpatient treatment, a lower dose of oral amoxicillin was non-inferior to a higher dose, and a 3-day duration was non-inferior to 7 days, according to the results of a randomized clinical trial published today in JAMA.
Two doses of the Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines were 93% and 96% effective, respectively, in preventing severe, critical, or fatal disease caused by the highly transmissible Delta (B1617.2) variant, a study today in Nature Medicine finds.
A pair of values-based incentive programs at US hospitals were linked to a decline in C difficile.
"As we await CDC's decision, we are not waiting on operations or logistics."
The group agreed on a goal of vaccinating at least 70% of the world's population by the middle of next year.
A third Pfizer COVID-19 vaccine dose is 92% more effective in reducing severe COVID-related outcomes than two doses of the same vaccine received at least 5 months previously, according to a large real-world study late last week in The Lancet.
Antibiotic prescribing during the early COVID-19 months in Canada dropped sharply, according to two new studies, one that looked at retail pharmacy trends across the country and one that focused on outpatient prescribing patterns in Ontario.
The secondary attack rate was 25% in fully vaccinated people and 38% in the unvaccinated.
The authors say all eligible people should get the vaccine ASAP, including those previously infected.
